Xifeng Zhang

机构：Jiangsu University, Jiujiang First People's Hospital, Putian University · ORCID：0000-0003-3403-9598

发表论文 97 篇 · 总被引 1308 次 · h-index 20

代表论文

• Tumor-Microenvironment-Activatable Nanoparticle Mediating Immunogene Therapy and M2 Macrophage-Targeted Inhibitor for Synergistic Cancer Immunotherapy (2024 · ACS Nano · 被引 72)
• The Changing Environment in Postgraduate Education in Orthopedic Surgery and Neurosurgery and Its Impact on Technology-Driven Targeted Interventional and Surgical Pain Management: Perspectives from Europe, Latin America, Asia, and The United States (2023 · Journal of Personalized Medicine · 被引 31)
• A Glutathione‐Responsive System with Prodrug and Sensitization Strategies for Targeted Therapy of Glioma (2025 · Small · 被引 5)
• MEK inhibitors for the treatment of immunotherapy-resistant, AGK-BRAF fusion advanced acral melanoma: a case report and literature review (2025 · Journal of Cancer Research and Clinical Oncology · 被引 4)
• Application of an ultrasound-guided bilateral erector spinae plane block after the Nuss procedure for pectus excavatum in children: a retrospective cohort study with propensity score matching (2023 · Frontiers in Pediatrics · 被引 4)
• PM2.5 enhances DRP1-mediated mitochondrial fission to induce ferroptosis and exacerbate asthma through the AHR-HSP90-PKM2 pathway (2025 · Toxicology and Applied Pharmacology · 被引 2)